Therapies that target remyelination are under development and a non-invasive specific and sensitive imaging biomarker to evaluate their efficacy within the timescale of a clinical trial is vital. Using myelin water imaging, we followed a group of relapsing-remitting and progressive multiple sclerosis (MS) participants and healthy controls over approximately 2 years to compare their rate of change in myelin water fraction. A significant decrease in mean myelin water fraction was found over 2 years in the normal-appearing white matter of participants with MS, with a larger decrease in relapsing-remitting MS than progressive MS.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords